Drawing for MERGE LABS

USPTO serial 99500413

MERGE LABS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MCDORMAN, ROGER THOMAS
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with MERGE LABS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 Page Mill RoadPalo Alto, CA 94304United States

Goods and services

ClassDescriptionStatusFirst use
005gene therapy products, namely, pharmaceutical preparations for enabling the use of brain computer interface (BCI) systemsACTIVE—
009Downloadable and recorded software for providing direct interfaces between the brain and computer systems; downloadable and recorded software for directly controlling and communicating with computers and electronic devices via neural activity; downloadable and recorded software for controlling brain-computer interface (BCI) devices; downloadable and recorded software for interpreting and decoding neural activity; downloadable and recorded software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems; Brain-computer interface (BCI) devices that allow users to interface with computer hardware via brain activity; interfaces for computers in the nature of implants for directly controlling and communicating with computers and electronic devices via neural activityACTIVE—
010Brain-computer interface (BCI) devices being ultrasound transceiver implants for medical use; implants for directly controlling and communicating with computers and electronic devices via neural activity for medical purposes; medical devices for opening the blood-brain barrier; electronic devices, namely, computer displays, monitors, and controllers therefor used for directly modulating brain states for the purpose of diagnosis of conditions and detecting brain activity in an individual; medical devices for detecting brain functionACTIVE—
042Providing online non-downloadable software featuring software that provides a direct interface between the brain and computer systems; software as a service (SAAS) services featuring software that allows users to directly control and communicate with computers using neural activity; providing online non-downloadable software for controlling brain-computer interface (BCI) devices; providing online non-downloadable software and recorded software for interpreting and decoding neural activity; providing online non-downloadable software for identifying biomarkers to train artificial intelligence (AI) and machine learning (ML) systems; research and development in the field of brain-computer interfaces (BCI), direct communication between brain activity and computers, neurostimulation, and therapeutics; providing information in the field of brain-computer interfaces (BCI); gene therapy research; research and development in the field of artificial intelligence (AI) and machine learning (ML) for use in brain-computer interface (BCI) devices, neurostimulation, and therapeuticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 14, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 22, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 22, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 22, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 2, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 25, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2026DOCKASSIGNED TO EXAMINER—
Nov 17, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 17, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance